This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print this page

Life Sciences

Life sciences organizations face the challenge of converting great discoveries and research breakthroughs into public acceptance and market success. For companies specializing in pharmaceuticals, biotechnology, medical products and technology and medical devices, the life sciences are changing at a remarkable rate. Deloitte LLP’s Life Sciences practice works with our clients to shape the evolution of the industry. 

Learn more about our Health Sciences practice and Deloitte Recap.

More Featured insights

  • Hospital consolidation: Analysis of acute sector M&A activity
    How well did studied hospitals perform financially post-merger? Deloitte analyzed 101 acute hospital sector M&A transactions in 2007-2008 and discovered mixed results.
  • Deloitte Survey of US Physicians
    The Deloitte Survey of U.S. Physicians provides data-driven insights on physicians’ perceptions of the health care system and their thoughts on health care reform.
  • 2013: What’s around the corner for the health care industry
    2013: What’s around the corner for the health care industry
    Dr. Paul Keckley shares his views on the potential impacts to industry stakeholders of Affordable Care Act implementation, cost containment, and other developments within the next year and beyond.
  • Health care reform and life sciences: Threat, opportunity or both?
    Health care reform and life sciences: Threat, opportunity or both?
    Enhancing innovation, reducing costs, widening market access, and changing sales models are seen as major impacts from health care reforms around the world, according to a new report released by Deloitte Touche Tohmatsu Limited Global Life Sciences and Health Care industry group.
  • The Financial Times 2013 U.S. healthcare and life sciences conference
    The Financial Times 2013 U.S. healthcare and life sciences conference
    Register for the June 6 - "2013 Financial Times U.S. Healthcare and Life Sciences conference" which is jointly developed by Deloitte and the Financial Times and is a premier gathering for senior life science executives, industry leaders, payers and financiers from around the world.

Join Our Team

Explore Health Sciences career opportunities: Experienced Hires | Students

 

Stay Updated

Subscribe to receive updates from Deloitte's Life Sciences practice:
Life Sciences Email E-mail |   Life Sciences RSS RSS ( What is RSS?) |  Life Sciences Twitter Twitter 

 

 

 

 

 

 

 

Dig Deeper

  • IRS accepting applications for pre-filing agreements that involve medical device excise tax issues
    On May 16, 2013, the IRS updated its Frequently Asked Questions list related to the medical device excise tax (“MDET”), specifically addressing Pre-Filing Agreements.
  • Deloitte survey of U.S. health care consumers
    Explore the resource library.
  • Deloitte health: Resources, reform, results
    A library of resources.
  • Life sciences and health reform: No going back
    Watch the podcast.
  • In the news: Deloitte health care & life sciences
    Straight from the headlines.
  • Code Blue: Brand resuscitation
    Four steps to determine if a brand is worth saving – and ways to save it

More Events

  • Opportunities and challenges in mHealth
    Register for June 18 webcast.
  • What is keeping the health care C-suite up at night?
    View the archived webcast.
  • Health sciences Dbriefs webcasts library
    Look ahead. Catch up on past events.

Share this page

Email this Send to LinkedIn Send to Facebook Tweet this More sharing options

Stay connected

Copyright © 2013 Deloitte Development LLC.
All rights reserved.
36 USC 220506

Official Professional Services Sponsor; Professional Services means audit, tax, consulting and financial advisory services.

About this site

Follow us